What research is currently being done to help individuals with harmful BRCA1 or BRCA2 mutations?
Research studies are being conducted to find newer and better ways of detecting, treating, and preventing cancer in BRCA1 and BRCA2 mutation carriers. Additional studies are focused on improving genetic counseling methods and outcomes. Our knowledge in these areas is evolving rapidly. Information about active clinical trials (research studies with people) for individuals with BRCA1 or BRCA2 mutations is available on NCI’s Web site. The following links will initiate searches of NCI’s clinical trials database and retrieve lists of trials open to individuals with BRCA1 or BRCA2 mutations. • BRCA1 mutation carriers • BRCA2 mutation carriers In addition, NCI’s CIS can provide information about clinical trials and help with clinical trial searches (see below for contact information).